JP2016519080A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519080A5 JP2016519080A5 JP2016503019A JP2016503019A JP2016519080A5 JP 2016519080 A5 JP2016519080 A5 JP 2016519080A5 JP 2016503019 A JP2016503019 A JP 2016503019A JP 2016503019 A JP2016503019 A JP 2016503019A JP 2016519080 A5 JP2016519080 A5 JP 2016519080A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkyl
- halogen
- cooh
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 93
- 125000000217 alkyl group Chemical group 0.000 claims description 69
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 66
- 229910052736 halogen Inorganic materials 0.000 claims description 66
- 150000002367 halogens Chemical class 0.000 claims description 61
- 229910052739 hydrogen Inorganic materials 0.000 claims description 56
- 239000001257 hydrogen Substances 0.000 claims description 50
- 239000003795 chemical substances by application Substances 0.000 claims description 38
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 31
- 150000002148 esters Chemical class 0.000 claims description 28
- 125000003118 aryl group Chemical group 0.000 claims description 26
- 239000007850 fluorescent dye Substances 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 22
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 150000002431 hydrogen Chemical class 0.000 claims description 19
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 16
- 125000004429 atom Chemical group 0.000 claims description 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 14
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- PIGFYZPCRLYGLF-UHFFFAOYSA-N Aluminum nitride Chemical compound [Al]#N PIGFYZPCRLYGLF-UHFFFAOYSA-N 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 12
- 125000005605 benzo group Chemical group 0.000 claims description 12
- 201000010099 disease Diseases 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 229910052717 sulfur Inorganic materials 0.000 claims description 12
- 125000002947 alkylene group Chemical group 0.000 claims description 10
- 125000000304 alkynyl group Chemical group 0.000 claims description 10
- 125000000623 heterocyclic group Chemical group 0.000 claims description 10
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 10
- 125000004076 pyridyl group Chemical group 0.000 claims description 10
- 239000000523 sample Substances 0.000 claims description 10
- 125000001424 substituent group Chemical group 0.000 claims description 10
- 125000003107 substituted aryl group Chemical group 0.000 claims description 10
- -1 N-hydroxysulfosuccinimide ester Chemical class 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 150000001540 azides Chemical class 0.000 claims description 8
- 229910052711 selenium Inorganic materials 0.000 claims description 8
- 238000002372 labelling Methods 0.000 claims description 7
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 238000003384 imaging method Methods 0.000 claims description 5
- 238000012634 optical imaging Methods 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 150000001345 alkine derivatives Chemical class 0.000 claims description 4
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 4
- 125000001188 haloalkyl group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 claims description 4
- 239000012948 isocyanate Substances 0.000 claims description 4
- 150000002513 isocyanates Chemical class 0.000 claims description 4
- 150000002540 isothiocyanates Chemical class 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 150000003573 thiols Chemical class 0.000 claims description 4
- 239000012472 biological sample Substances 0.000 claims description 3
- 238000011156 evaluation Methods 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 201000001320 Atherosclerosis Diseases 0.000 claims description 2
- 208000020084 Bone disease Diseases 0.000 claims description 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
- 208000035473 Communicable disease Diseases 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 claims description 2
- 206010061218 Inflammation Diseases 0.000 claims description 2
- 208000007201 Myocardial reperfusion injury Diseases 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 102000015636 Oligopeptides Human genes 0.000 claims description 2
- 108010038807 Oligopeptides Proteins 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000014633 carbohydrates Nutrition 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 230000007613 environmental effect Effects 0.000 claims description 2
- 208000030533 eye disease Diseases 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 208000016361 genetic disease Diseases 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 235000001727 glucose Nutrition 0.000 claims description 2
- 208000026278 immune system disease Diseases 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 238000011503 in vivo imaging Methods 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 230000004054 inflammatory process Effects 0.000 claims description 2
- 125000005647 linker group Chemical group 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 230000004807 localization Effects 0.000 claims description 2
- 208000030159 metabolic disease Diseases 0.000 claims description 2
- 208000031225 myocardial ischemia Diseases 0.000 claims description 2
- 230000004770 neurodegeneration Effects 0.000 claims description 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 150000008300 phosphoramidites Chemical class 0.000 claims description 2
- NAYYNDKKHOIIOD-UHFFFAOYSA-N phthalamide Chemical compound NC(=O)C1=CC=CC=C1C(N)=O NAYYNDKKHOIIOD-UHFFFAOYSA-N 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 208000023504 respiratory system disease Diseases 0.000 claims description 2
- 208000037803 restenosis Diseases 0.000 claims description 2
- 208000017520 skin disease Diseases 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 238000003325 tomography Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 32
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 claims 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical class OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 claims 1
- 238000000338 in vitro Methods 0.000 description 2
- GVJXGCIPWAVXJP-UHFFFAOYSA-N 2,5-dioxo-1-oxoniopyrrolidine-3-sulfonate Chemical class ON1C(=O)CC(S(O)(=O)=O)C1=O GVJXGCIPWAVXJP-UHFFFAOYSA-N 0.000 description 1
- HFHFGHLXUCOHLN-UHFFFAOYSA-N 2-fluorophenol Chemical class OC1=CC=CC=C1F HFHFGHLXUCOHLN-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361798562P | 2013-03-15 | 2013-03-15 | |
| US61/798,562 | 2013-03-15 | ||
| PCT/US2014/029224 WO2014144702A2 (en) | 2013-03-15 | 2014-03-14 | 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019103596A Division JP7018913B2 (ja) | 2013-03-15 | 2019-06-03 | ４，４－二置換シクロヘキシル架橋ヘプタメチンシアニン色素およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519080A JP2016519080A (ja) | 2016-06-30 |
| JP2016519080A5 true JP2016519080A5 (enExample) | 2017-04-20 |
| JP6580552B2 JP6580552B2 (ja) | 2019-09-25 |
Family
ID=50631078
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503019A Active JP6580552B2 (ja) | 2013-03-15 | 2014-03-14 | ４，４−二置換シクロヘキシル架橋ヘプタメチンシアニン色素およびその使用 |
| JP2019103596A Active JP7018913B2 (ja) | 2013-03-15 | 2019-06-03 | ４，４－二置換シクロヘキシル架橋ヘプタメチンシアニン色素およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019103596A Active JP7018913B2 (ja) | 2013-03-15 | 2019-06-03 | ４，４－二置換シクロヘキシル架橋ヘプタメチンシアニン色素およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US9897604B2 (enExample) |
| EP (2) | EP2970674B1 (enExample) |
| JP (2) | JP6580552B2 (enExample) |
| CN (1) | CN105339436B (enExample) |
| AU (1) | AU2014228808C1 (enExample) |
| CA (1) | CA2901000C (enExample) |
| WO (1) | WO2014144702A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104788433A (zh) | 2005-09-02 | 2015-07-22 | Visen医药公司 | 生物相容的含n,n-二取代磺酰胺的荧光染料标记 |
| WO2007136413A2 (en) | 2005-12-22 | 2007-11-29 | Visen Medical, Inc. | Biocompatible fluorescent metal oxide nanoparticles |
| CA2749108C (en) | 2008-01-18 | 2017-06-27 | Visen Medical, Inc. | Intramolecularly-quenched fluorescent imaging agents |
| AU2012253502C1 (en) | 2011-05-09 | 2017-12-14 | Visen Medical, Inc. | Carbonic anhydrase targeting agents and methods of using same |
| JP6606487B2 (ja) | 2013-03-15 | 2019-11-13 | ビセン メディカル， インコーポレイテッド | ｉｎｖｉｔｒｏおよびｉｎｖｉｖｏイメージングおよび検出のための置換シラキサンテニウム赤色〜近赤外蛍光色素 |
| CN105339436B (zh) | 2013-03-15 | 2018-05-25 | 文森医学公司 | 4,4-二取代环己基桥连七甲川花菁染料及其应用 |
| WO2018031448A1 (en) | 2016-08-11 | 2018-02-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Near-ir light-cleavable conjugates and conjugate precursors |
| CN107400080B (zh) * | 2017-07-27 | 2020-03-31 | 中国科学院烟台海岸带研究所 | 一种基于花菁的有机化合物及其中间体的应用 |
| JP2020050610A (ja) * | 2018-09-27 | 2020-04-02 | 国立研究開発法人理化学研究所 | バイオイメージング剤 |
| CN109985252A (zh) * | 2019-05-10 | 2019-07-09 | 南京鼓楼医院 | 一种新型双模态小分子造影剂及其制备方法与应用 |
| CN110642839B (zh) * | 2019-08-14 | 2022-04-01 | 深圳大学 | 一种纳米探针及其制备方法与应用 |
| CN113045563A (zh) * | 2019-12-27 | 2021-06-29 | 上海泓博智源医药股份有限公司 | 一种感蓝光谱增感剂的制备方法 |
| CN112920171A (zh) * | 2021-01-29 | 2021-06-08 | 南京邮电大学 | 一种含四嗪单元的花菁化合物及其制备方法和应用 |
| CN113350336B (zh) * | 2021-07-01 | 2022-06-10 | 中国人民解放军陆军军医大学 | 一种七甲川吲哚花菁或其衍生物的用途 |
| CN115403503B (zh) * | 2022-09-02 | 2023-05-26 | 中国药科大学 | 七甲川花菁素类染料偶联物、制法、药物组合物和应用 |
| CN117169182B (zh) * | 2023-08-30 | 2024-03-15 | 广州沙艾生物科技有限公司 | 一种干细胞治疗制剂体外效力检测方法及其应用 |
Family Cites Families (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4219335A (en) | 1978-09-18 | 1980-08-26 | E. I. Du Pont De Nemours And Company | Immunochemical testing using tagged reagents |
| US6086737A (en) | 1984-03-29 | 2000-07-11 | Li-Cor, Inc. | Sequencing near infrared and infrared fluorescence labeled DNA for detecting using laser diodes and suitable labels therefor |
| US5571388A (en) * | 1984-03-29 | 1996-11-05 | Li-Cor, Inc. | Sequencing near infrared and infrared fluorescense labeled DNA for detecting using laser diodes and suitable labels thereof |
| JP2521702B2 (ja) * | 1985-04-26 | 1996-08-07 | 株式会社リコー | 光情報記録媒体 |
| JPS6250187A (ja) * | 1985-08-29 | 1987-03-04 | Nippon Kayaku Co Ltd | 耐光堅牢度向上法 |
| JPS62103192A (ja) * | 1985-10-30 | 1987-05-13 | Olympus Optical Co Ltd | 光情報記録媒体 |
| JPS62103190A (ja) * | 1985-10-30 | 1987-05-13 | Olympus Optical Co Ltd | 光情報記録媒体 |
| JPS62124986A (ja) * | 1985-11-27 | 1987-06-06 | Mitsubishi Chem Ind Ltd | 光学的記録媒体 |
| US6048982A (en) | 1986-04-18 | 2000-04-11 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
| JP2732275B2 (ja) * | 1989-01-20 | 1998-03-25 | キヤノン株式会社 | 光学記録媒体 |
| US5164297A (en) | 1990-05-03 | 1992-11-17 | Advanced Magnetics Inc. | Solvent mediated relaxation assay system |
| US5445970A (en) | 1992-03-20 | 1995-08-29 | Abbott Laboratories | Magnetically assisted binding assays using magnetically labeled binding members |
| AU5085793A (en) | 1992-09-04 | 1994-03-29 | General Hospital Corporation, The | Biocompatible polymers containing diagnostic or therapeutic moieties |
| US6593148B1 (en) * | 1994-03-01 | 2003-07-15 | Li-Cor, Inc. | Cyanine dye compounds and labeling methods |
| DE4445065A1 (de) | 1994-12-07 | 1996-06-13 | Diagnostikforschung Inst | Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung |
| JPH08234463A (ja) | 1994-12-27 | 1996-09-13 | Fuji Photo Film Co Ltd | スキャニング露光を用いる画像形成方法 |
| IT1276833B1 (it) | 1995-10-09 | 1997-11-03 | Sorin Biomedica Cardio Spa | Coloranti fluorescenti della famiglia della solfo benz e indocianina |
| US5958667A (en) * | 1996-07-24 | 1999-09-28 | Agfa-Gevaert | Photothermographic recording material comprising IR-sensitizing dyes |
| JP3794793B2 (ja) * | 1996-07-24 | 2006-07-12 | アグフア−ゲヴエルト，ナームローゼ・フエンノートシヤツプ | 増感色素を含むフオトサーモグラフイ記録材料及びそのための記録法 |
| EP0821266A1 (en) | 1996-07-24 | 1998-01-28 | Agfa-Gevaert N.V. | Photothermographic recording material comprising sensitizing dyes and a recording process therefor |
| US5876915A (en) * | 1996-07-24 | 1999-03-02 | Agfa-Gevaert | Photothermographic recording material comprising sensitizing dyes and a recording process therefor |
| DE69735697T2 (de) * | 1996-07-24 | 2007-01-18 | Agfa-Gevaert | Verfahren zur Herstellung eines photothermographischen Infrarotmaterials, das einen Spektralsensibilisator und einen Stilbenderivat-Supersensibilisator enthält und ein Aufzeichnungsverfahren |
| EP0821271B1 (en) | 1996-07-24 | 2006-04-19 | Agfa-Gevaert | Process for preparing an Infra-red photothermographic material comprising a spectral sensitizer and a stilbene derivative supersensitizer and image recording method |
| US6027709A (en) * | 1997-01-10 | 2000-02-22 | Li-Cor Inc. | Fluorescent cyanine dyes |
| DE19717904A1 (de) | 1997-04-23 | 1998-10-29 | Diagnostikforschung Inst | Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie |
| US6046585A (en) | 1997-11-21 | 2000-04-04 | Quantum Design, Inc. | Method and apparatus for making quantitative measurements of localized accumulations of target particles having magnetic particles bound thereto |
| JPH11185836A (ja) | 1997-12-16 | 1999-07-09 | Fuji Photo Film Co Ltd | 光電変換素子および光再生型光電気化学電池 |
| US6083486A (en) | 1998-05-14 | 2000-07-04 | The General Hospital Corporation | Intramolecularly-quenched near infrared fluorescent probes |
| US6592847B1 (en) | 1998-05-14 | 2003-07-15 | The General Hospital Corporation | Intramolecularly-quenched near infrared flourescent probes |
| EP1065250B1 (en) | 1999-07-02 | 2004-12-08 | Visen Medical, Inc. | New fluorescent cyanine labels containing a sulfamido linker arm |
| CA2424454C (en) * | 2000-09-19 | 2010-07-20 | Li-Cor, Inc. | Cyanine dyes |
| US7597878B2 (en) * | 2000-09-19 | 2009-10-06 | Li-Cor, Inc. | Optical fluorescent imaging |
| AU2001294859A1 (en) | 2000-09-29 | 2002-04-08 | Molecular Probes, Inc. | Modified carbocyanine dyes and their conjugates |
| AU2002236683A1 (en) | 2000-10-27 | 2002-05-21 | Beth Israel Deaconess Medical Center | Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates |
| US7383076B2 (en) | 2000-11-27 | 2008-06-03 | The General Hospital Corporation | Fluorescence-mediated molecular tomography |
| US6615063B1 (en) | 2000-11-27 | 2003-09-02 | The General Hospital Corporation | Fluorescence-mediated molecular tomography |
| EP1209205A1 (en) | 2000-11-28 | 2002-05-29 | Innosense S.r.l. | Improved process and method for the preparation of asymetric monofunctionalised indocyanine labelling reagents and obtained compounds |
| EP1213583A1 (en) | 2000-12-06 | 2002-06-12 | Innosense S.r.l. | General method for the covalent immobilisation of indicators in, or onto a support useful for the fabrication of optical sensors |
| EP1221465A1 (en) | 2001-01-03 | 2002-07-10 | Innosense S.r.l. | Symmetric, monofunctionalised polymethine dyes labelling reagents |
| US20030044353A1 (en) | 2001-01-05 | 2003-03-06 | Ralph Weissleder | Activatable imaging probes |
| AU2003207438A1 (en) | 2002-01-02 | 2003-07-24 | Visen Medical, Inc. | Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor |
| WO2003061711A2 (en) | 2002-01-16 | 2003-07-31 | Visen Medical, Inc. | Chromophore probes for optical imaging |
| AU2003225763A1 (en) | 2002-03-11 | 2003-09-29 | Visen Medical, Inc. | Optical imaging probes |
| EP1514093B1 (en) | 2002-06-04 | 2021-04-28 | Visen Medical, Inc. | Imaging volumes with arbitrary geometries in non-contact tomography |
| JP2004067816A (ja) * | 2002-08-05 | 2004-03-04 | Fuji Photo Film Co Ltd | セルロースアシレートフィルム及びその製造方法、並びに該フィルムを用いた光学フィルム、液晶表示装置及びハロゲン化銀写真感光材料 |
| JP2004083799A (ja) * | 2002-08-28 | 2004-03-18 | Fuji Photo Film Co Ltd | セルロースアシレートフィルム及びその製造方法、並びに該フィルムを用いた光学フィルム、液晶表示装置及びハロゲン化銀写真感光材料 |
| WO2004072906A1 (en) | 2003-02-05 | 2004-08-26 | The General Hospital Corporation | Method and system for free space optical tomography of diffuse media |
| WO2004108902A2 (en) | 2003-06-04 | 2004-12-16 | Visen Medical, Inc. | Biocompatible fluorescent silicon nanoparticles |
| EP1824379B1 (en) | 2004-12-08 | 2017-04-12 | The General Hospital Corporation | System and method for normalized fluorescence or bioluminescence imaging |
| US20060239916A1 (en) | 2005-01-07 | 2006-10-26 | Kai Licha | Use of cyanine dyes for the diagnosis of proliferative diseases |
| DK1937676T3 (en) | 2005-09-02 | 2017-03-06 | Visen Medical Inc | Biocompatible fluorescent imaging compounds |
| US8173819B2 (en) | 2005-09-02 | 2012-05-08 | Visen Medical, Inc. | Nicotinic and picolinic acid derived near-infrared fluorophores |
| CN104788433A (zh) | 2005-09-02 | 2015-07-22 | Visen医药公司 | 生物相容的含n,n-二取代磺酰胺的荧光染料标记 |
| DE602006020618D1 (de) | 2005-12-22 | 2011-04-21 | Visen Medical Inc | Kombiniertes röntgen- und optisches tomographie-bildgebungssystem |
| WO2007136413A2 (en) | 2005-12-22 | 2007-11-29 | Visen Medical, Inc. | Biocompatible fluorescent metal oxide nanoparticles |
| ITSV20060002A1 (it) * | 2006-01-19 | 2007-07-20 | Ferrania Technologies Spa | Colorante fluorescente di tipo cianinico |
| WO2007109364A2 (en) | 2006-03-20 | 2007-09-27 | The General Hospital Corporation | Intramolecularly quenched fluorochrome conjugates and methods of use |
| US8221721B2 (en) | 2007-02-09 | 2012-07-17 | Visen Medical, Inc. | Polycyclo dyes and use thereof |
| WO2008109832A2 (en) | 2007-03-08 | 2008-09-12 | Visen Medical, Inc. | Viable near-infrared fluorochrome labeled cells and methods of making and using same |
| US8314406B2 (en) | 2007-04-06 | 2012-11-20 | The General Hospital Corporation | Systems and methods for optical imaging using early arriving photons |
| US8492734B2 (en) | 2007-10-19 | 2013-07-23 | Visen Medical, Inc. | Imaging systems featuring waveguiding compensation |
| WO2009078970A1 (en) * | 2007-12-14 | 2009-06-25 | Biotium, Inc. | Fluorescent compounds |
| CA2749108C (en) | 2008-01-18 | 2017-06-27 | Visen Medical, Inc. | Intramolecularly-quenched fluorescent imaging agents |
| EP3673922A1 (en) | 2008-03-14 | 2020-07-01 | VisEn Medical, Inc. | Integrin targeting agents and methods of using same |
| EP2265181B1 (en) | 2008-03-25 | 2016-11-16 | Visen Medical, Inc. | Animal holder for in vivo tomographic imaging with multiple modalities and method |
| US8864821B2 (en) | 2008-11-26 | 2014-10-21 | Visen Medical, Inc. | Methods and compositions for identifying subjects at risk of developing stent thrombosis |
| EP2204194B1 (en) * | 2008-12-25 | 2017-08-02 | Canon Kabushiki Kaisha | Probe for a hair cell, and labelling method for a hair cell using the probe for a hair cell |
| EP2470887B1 (en) | 2009-08-28 | 2020-03-11 | VisEn Medical, Inc. | Systems for tomographic imaging in diffuse media using a hybrid inversion technique |
| CN102781307B (zh) | 2009-09-22 | 2016-01-20 | 文森医学公司 | 用于漫射性介质虚拟折射率匹配的系统和方法 |
| AU2012253502C1 (en) | 2011-05-09 | 2017-12-14 | Visen Medical, Inc. | Carbonic anhydrase targeting agents and methods of using same |
| CN104245954A (zh) | 2012-03-30 | 2014-12-24 | 文森医学公司 | 细菌成像剂及其使用方法 |
| WO2014028057A1 (en) | 2012-08-15 | 2014-02-20 | Visen Medical, Inc. | Prostate specific antigen agents and methods of using same for prostate cancer imaging |
| US20150182518A1 (en) * | 2012-10-26 | 2015-07-02 | Canon Kabushiki Kaisha | Cancer cell inhibitory drug and cancer stem-cell detection probe |
| CN105339436B (zh) | 2013-03-15 | 2018-05-25 | 文森医学公司 | 4,4-二取代环己基桥连七甲川花菁染料及其应用 |
| JP6606487B2 (ja) | 2013-03-15 | 2019-11-13 | ビセン メディカル， インコーポレイテッド | ｉｎｖｉｔｒｏおよびｉｎｖｉｖｏイメージングおよび検出のための置換シラキサンテニウム赤色〜近赤外蛍光色素 |
| WO2019067180A1 (en) * | 2017-09-29 | 2019-04-04 | Perkinelmer Health Sciences, Inc. | NIR-SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION |
-
2014
- 2014-03-14 CN CN201480016214.6A patent/CN105339436B/zh active Active
- 2014-03-14 WO PCT/US2014/029224 patent/WO2014144702A2/en not_active Ceased
- 2014-03-14 EP EP14721134.6A patent/EP2970674B1/en active Active
- 2014-03-14 CA CA2901000A patent/CA2901000C/en active Active
- 2014-03-14 EP EP18211794.5A patent/EP3489309A1/en active Pending
- 2014-03-14 AU AU2014228808A patent/AU2014228808C1/en active Active
- 2014-03-14 JP JP2016503019A patent/JP6580552B2/ja active Active
- 2014-03-17 US US14/215,930 patent/US9897604B2/en active Active
-
2018
- 2018-02-07 US US15/890,646 patent/US10473658B2/en active Active
-
2019
- 2019-06-03 JP JP2019103596A patent/JP7018913B2/ja active Active
- 2019-10-16 US US16/654,305 patent/US11193932B2/en active Active
-
2021
- 2021-11-10 US US17/454,300 patent/US20220178921A1/en not_active Abandoned
-
2024
- 2024-05-28 US US18/675,875 patent/US20240393330A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016519080A5 (enExample) | ||
| JP2016521254A5 (enExample) | ||
| ES2876874T3 (es) | Plataforma innovadora de tecnología para la unión específica de células necróticas | |
| JP7018913B2 (ja) | ４，４－二置換シクロヘキシル架橋ヘプタメチンシアニン色素およびその使用 | |
| Wang et al. | NIR scaffold bearing three handles for biocompatible sequential click installation of multiple functional arms | |
| JP2015532641A5 (enExample) | ||
| CN106977628B (zh) | 吲哚菁化合物、其合成及精制法、诊断用组合物、生物体内动态测定装置及循环可视化装置 | |
| Li et al. | Self-assembled NIR-II fluorophores with ultralong blood circulation for cancer imaging and image-guided surgery | |
| JP2010518236A5 (enExample) | ||
| Harmatys et al. | In vivo imaging of bone using a deep-red fluorescent molecular probe bearing multiple iminodiacetate groups | |
| EP2971065B1 (en) | Activity-based probe compounds, compositions, and methods of use | |
| JP5500875B2 (ja) | 新規化合物、該新規化合物を用いたプローブ及び該新規化合物もしくは該プローブを用いた蛍光イメージング用造影剤 | |
| CN103687854A (zh) | 碳酸酐酶靶向剂及其使用方法 | |
| JP2015532641A (ja) | 前立腺がんイメージングのための前立腺特異的抗原薬剤およびその使用方法 | |
| WO2008109832A2 (en) | Viable near-infrared fluorochrome labeled cells and methods of making and using same | |
| EP3510380B1 (en) | Activity-based probe compounds, compositions, and methods of use | |
| KR101188979B1 (ko) | 광역학 진단 또는 치료를 위한 생체 적합성 고분자와 광감작제의 결합체 및 이의 제조방법 | |
| CN106999609B (zh) | 用于荧光成像的ir染料 | |
| US20200340920A1 (en) | Hydrophilic silicon-rhodamine fluorescent probes and use thereof | |
| TW202214308A (zh) | 生物成像劑 | |
| US12306194B2 (en) | Reagent for fluorescence imaging of lipid droplets in cell and tissue | |
| US9289515B2 (en) | Multivalent fluorescent probes | |
| US20150044141A1 (en) | Synthesis and application of novel imaging agents conjugated to dpa 713 analogs for imaging inflammation | |
| WO2005061456A1 (ja) | 近赤外蛍光造影剤 | |
| JP6711601B2 (ja) | 光音響イメージング用造影剤 |